Claim this
Write to the

About Annexon

Annexon is developing drugs to inhibit the complement cascade, which the company believes is a key mechanism in neurodegenerative diseases. These drugs are expected to halt the progression of these ...

Annexon describes itself with 3 words or categories

Health CarePharmaceuticalsBiotechnology



Case Study

Competitive Landscape

  • #DATA_YEAR# : $
    from #DATA_FROM#
  • News

    No news added yet.

    Company Size

    1-10 employees